From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

More from the Women’s Health Initiative: Benefits for Estrogen?

Women who began taking estrogen in their 50s had lower coronary-artery calcium scores than placebo users.

Although initial findings from the Women’s Health Initiative (WHI) indicated substantial risks to use of estrogen in postmenopausal women, a newer study showed no increase in coronary heart disease risks due to hormone therapy for any outcome in women aged 50 to 59 at HT initiation (Journal Watch Apr 10 2007). Now, in a WHI substudy, coronary-artery calcification was assessed in 1064 women who were aged 50 to 59 at randomization to conjugated equine estrogen alone (0.625 mg/day) or placebo; the women underwent computed tomography of the heart after a mean 7.4 years of treatment and 1.3 years after trial completion.

The mean coronary-artery calcium score was significantly lower with estrogen than with placebo. In an analysis restricted to data for women with at least 80% adherence to estrogen or placebo for at least 5 years, the multivariable odds ratios for high levels of coronary-artery calcium were about 60% lower in estrogen users.

Comment: These data support the hypothesis that estrogen therapy has cardioprotective effects in younger women. Accompanying editorialists concur and suggest that estrogen’s effects on the vasculature are mediated in part by age and in part by vascular health at time of estrogen initiation. The findings offer reassurance that estrogen does not increase heart disease risk when used for treatment of menopausal symptoms in healthy women aged 50 to 59 — but the findings do not indicate that estrogen should be used to prevent cardiovascular disease.

Robert W. Rebar, MD

Published in Journal Watch General Medicine June 20, 2007

Citation(s):

Manson JE et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007 Jun 21; 356:2591-602.

Mendelsohn ME and Karas RH. HRT and the young at heart. N Engl J Med 2007 Jun 21; 356:2639-41.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.